Successful response with romidepsin in relapsed peripheral T-cell lymphoma, not otherwise specified with leukemic progression
Division of Hematology, Shonan Kamakura General Hospital, Japan
Shuku Sato, M.D.
Division of Hematology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa 247-8533, Japan
Published online: August 4, 2020.
© The Korean Journal of Hematology. All rights reserved.
This is an Open Access article distributed unAcute myeloid leukemia, New FDA approvalsder the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0
) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.